|
Delayed
TEL AVIV STOCK EXCHANGE
05:26:14 2026-10-21 EDT
|
5-day change | 1st Jan Change | ||
| 116.50 ILa | -0.77% |
|
-4.12% | -61.24% |
| 10-06 | Evogene Enters into Cooperation Agreement with L.I.A. Pure Capital | CI |
| 10-06 | Evogene Ltd. Announces Appointment of Pure Capital Group Nominee Directors | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 6M | - | - | - | ||
| 66.34B | |||||
| 52.92B | |||||
| 54.82B | |||||
| 44.09B | |||||
| 43.72B |
- Stock Market
- Stocks
- EVGN Stock
- Charts Evogene Ltd.
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
